15-93014724-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001271.4(CHD2):​c.4721G>C​(p.Gly1574Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0257 in 1,613,986 control chromosomes in the GnomAD database, including 635 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1574V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.019 ( 38 hom., cov: 32)
Exomes 𝑓: 0.026 ( 597 hom. )

Consequence

CHD2
NM_001271.4 missense

Scores

1
3
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 6.86

Publications

10 publications found
Variant links:
Genes affected
CHD2 (HGNC:1917): (chromodomain helicase DNA binding protein 2) The CHD family of proteins is characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. CHD genes alter gene expression possibly by modification of chromatin structure thus altering access of the transcriptional apparatus to its chromosomal DNA template. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
CHD2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy 94
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myoclonic-astatic epilepsy
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001271.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0034458637).
BP6
Variant 15-93014724-G-C is Benign according to our data. Variant chr15-93014724-G-C is described in ClinVar as Benign. ClinVar VariationId is 257712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0194 (2954/152174) while in subpopulation NFE AF = 0.0301 (2044/67988). AF 95% confidence interval is 0.029. There are 38 homozygotes in GnomAd4. There are 1363 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2954 Unknown,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001271.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHD2
NM_001271.4
MANE Select
c.4721G>Cp.Gly1574Ala
missense
Exon 37 of 39NP_001262.3O14647-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHD2
ENST00000394196.9
TSL:5 MANE Select
c.4721G>Cp.Gly1574Ala
missense
Exon 37 of 39ENSP00000377747.4O14647-1
CHD2
ENST00000626874.2
TSL:1
c.4721G>Cp.Gly1574Ala
missense
Exon 37 of 38ENSP00000486629.1O14647-2
CHD2
ENST00000625662.3
TSL:5
n.*892G>C
non_coding_transcript_exon
Exon 33 of 35ENSP00000486007.2A0A0D9SEU0

Frequencies

GnomAD3 genomes
AF:
0.0194
AC:
2954
AN:
152056
Hom.:
38
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00529
Gnomad AMI
AF:
0.00987
Gnomad AMR
AF:
0.0103
Gnomad ASJ
AF:
0.0147
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00352
Gnomad FIN
AF:
0.0403
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0301
Gnomad OTH
AF:
0.0134
GnomAD2 exomes
AF:
0.0206
AC:
5173
AN:
251390
AF XY:
0.0208
show subpopulations
Gnomad AFR exome
AF:
0.00468
Gnomad AMR exome
AF:
0.00758
Gnomad ASJ exome
AF:
0.0147
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0403
Gnomad NFE exome
AF:
0.0313
Gnomad OTH exome
AF:
0.0223
GnomAD4 exome
AF:
0.0263
AC:
38452
AN:
1461812
Hom.:
597
Cov.:
31
AF XY:
0.0257
AC XY:
18694
AN XY:
727208
show subpopulations
African (AFR)
AF:
0.00376
AC:
126
AN:
33480
American (AMR)
AF:
0.00816
AC:
365
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0143
AC:
374
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00421
AC:
363
AN:
86250
European-Finnish (FIN)
AF:
0.0390
AC:
2082
AN:
53418
Middle Eastern (MID)
AF:
0.00191
AC:
11
AN:
5764
European-Non Finnish (NFE)
AF:
0.0304
AC:
33853
AN:
1111946
Other (OTH)
AF:
0.0211
AC:
1276
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
1855
3710
5566
7421
9276
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1226
2452
3678
4904
6130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0194
AC:
2954
AN:
152174
Hom.:
38
Cov.:
32
AF XY:
0.0183
AC XY:
1363
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.00527
AC:
219
AN:
41520
American (AMR)
AF:
0.0103
AC:
157
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0147
AC:
51
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5174
South Asian (SAS)
AF:
0.00353
AC:
17
AN:
4820
European-Finnish (FIN)
AF:
0.0403
AC:
427
AN:
10602
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0301
AC:
2044
AN:
67988
Other (OTH)
AF:
0.0133
AC:
28
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
145
289
434
578
723
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0217
Hom.:
32
Bravo
AF:
0.0164
Asia WGS
AF:
0.00549
AC:
19
AN:
3478
EpiCase
AF:
0.0268
EpiControl
AF:
0.0265

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
not provided (2)
-
-
1
Developmental and epileptic encephalopathy 94 (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.16
CADD
Benign
21
DANN
Benign
0.19
DEOGEN2
Benign
0.068
T
Eigen
Benign
-0.14
Eigen_PC
Benign
0.078
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.87
D
MetaRNN
Benign
0.0034
T
MetaSVM
Benign
-0.58
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
6.9
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-0.65
N
REVEL
Uncertain
0.36
Sift
Benign
0.89
T
Sift4G
Benign
0.87
T
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.054
gMVP
0.24
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs56227200;
hg19: chr15-93557954;
COSMIC: COSV99063985;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.